- Warts treatment products and procedures, addressing benign skin growths caused primarily by the human papillomavirus (HPV), are becoming essential components of dermatological care due to rising awareness of skin health, increased access to treatment options, and greater emphasis on aesthetic appearance across age groups
- The escalating demand for warts treatment is primarily fueled by the growing incidence of HPV-related infections, increasing preference for non-invasive treatments, and expanding availability of over-the-counter products including topical creams, cryotherapy kits, and immunomodulators
- North America dominates the warts treatment market with the largest revenue share of 39.1% in 2024, characterized by high awareness of HPV-related conditions, greater access to advanced dermatological services, and strong healthcare infrastructure
- Asia-Pacific is expected to be the fastest growing region in the warts treatment market during the forecast period due to increasing healthcare expenditure, improving access to dermatological treatments, and growing consumer awareness of HPV prevention and skincare
- Verruca Vulgaris segment dominates the warts treatment market with a market share of 52.8% in 2024, driven by its high prevalence, especially on hands and fingers, and greater demand for accessible, over-the-counter treatment options
